Table 2. Number (%) of first AIDS or death events and follow-up time by vaccine response status.
| Anti-HBs<10 IU/L (N = 473) | Anti-HBs≥10 IU/L (N = 322) | P | |
| Sequence of initial event type, N (%) | <0.001 | ||
| No event | 368 (77.8) | 305 (94.7) | |
| AIDS | 38 (8.0) | 6 (1.9) | |
| AIDS then death | 41 (8.9) | 6 (1.9) | |
| Death | 26 (5.5) | 5 (1.6) | |
| Initial AIDS event by type, N | |||
| Pneumocystis jiroveci pneumonia | 15 | 2 | |
| Candidiasis | 14 | 3 | |
| Wasting | 9 | 0 | |
| Mycobacterium avium -complex infection | 7 | 0 | |
| Kaposi sarcoma | 7 | 0 | |
| Non-Hodgkin's lymphoma | 4 | 1 | |
| Cryptosporidiosis | 4 | 0 | |
| AIDS-related dementia | 3 | 0 | |
| Cryptococcosis | 3 | 1 | |
| Pneumonia | 3 | 0 | |
| Cytomegalovirus disease | 2 | 2 | |
| Toxoplasmosis | 2 | 1 | |
| Progressive multifocal leukoencephalopathy | 2 | 0 | |
| Herpes simplex virus | 2 | 0 | |
| Mycobacterium tuberculosis | 1 | 1 | |
| Histoplasmosis | 1 | 0 | |
| Coccidiomycosis | 0 | 1 | |
| Total number of events per person, N (%) | <0.001 | ||
| 0 | 368 (77.8) | 305 (94.7) | |
| 1 | 55 (11.6) | 9 (2.8) | |
| 2 | 23 (4.9) | 6 (1.9) | |
| 3 | 13 (2.8) | 1 (0.3) | |
| 4 or more | 14 (3.0) | 1 (0.3) | |
| Follow-up time | |||
| Total years | 2,236 | 1,636 | |
| Median (IQR) years | 3.5 (1.6–6.5) | 3.8 (1.7–7.3) |
NOTE. Anti-HBs, hepatitis B surface antibody.